To extend our observations to clinical samples, we checked the PRMT5 transcript and protein levels along with the PRMT5-mediated modifications H4R3me2s and H3R8me2s in patient-derived breast cancer cell line BC8322, subjected to hypoxia. Here, PRMT5 is linked to breast carcinoma.